Medical information
12 articles shown
How Long Does Chemo After Colorectal Cancer Surgery Last? Understanding Why Adjuvant Chemotherapy Is a Fixed Course — Not "Forever"
Adjuvant chemotherapy after colorectal cancer surgery is not lifelong but a fixed course, usually about three to six months (often roughly 8–12 cycles), and the exact number may be adjusted for side effects and tolerance — so it helps to ask your care team directly how many cycles are planned and when it will end.
Menopause After Cancer Surgery — Weighing Hormone Therapy for Hot Flashes, Insomnia, and Joint Pain, and Understanding Non-Hormonal Options for Survivors
When a cancer survivor is offered hormone therapy for menopausal symptoms, its safety depends on the type of cancer rather than the diagnosis alone; this article explains how gynecology and oncology should decide together and outlines non-hormonal options for hot flashes, joint pain, and bone loss.
A Sudden Sharp Pain a Year After Cancer Surgery — Why New Pain Isn't Always Recurrence, and How to Tell Everyday Aches From Warning Signs
New, sharp abdominal pain a year after gastric or other abdominal cancer surgery does not always mean recurrence. This article explains common causes such as adhesions, healing nerves, and post-gastrectomy digestion, outlines the warning signs that warrant prompt medical attention, and suggests recording symptoms when moving up a follow-up visit.
When the Patch and Pills Don't Help but an Injection Does — Understanding Breakthrough Pain and the Difference Between Long-Acting and Fast-Acting Pain Medicines
Explains why pain can vary by day and by chemotherapy cycle through the framework of background pain control versus breakthrough pain, clarifying the different roles of patches, long-acting pills, and fast-acting injections, and how to recognize when baseline pain relief is insufficient.
When Your Report Says 'HER2 2+/3+': Understanding Biomarker Testing and Why the Same Marker Can Change Treatment Across Cancers
A plain-language explainer on what a HER2 (human epidermal growth factor receptor 2) score of 0/1+/2+/3+ on a pathology report means, why a biomarker can change targeted-therapy options across different cancers, and why reporting side-effect signals such as lung inflammation early matters.
When Your Chemo Is Switched From 'First-Line' to 'Second-Line' — Understanding 'Lines of Therapy' in Metastatic Colorectal Cancer
An easy explanation of what "lines of therapy" mean in metastatic colorectal cancer, why switching from FOLFOX to FOLFIRI is a planned next step rather than a failure, and how stabbing pain relates — or does not relate — to whether treatment is working.
Seeing a Banner for 'Proton Therapy' and Wondering What It Is — How It Differs from Standard Radiation, When It's Considered, and How to Check Coverage
A plain-language explainer on how proton therapy differs from standard X-ray radiation, when it is typically considered, and why coverage should be confirmed with the treating hospital.
When You Start Searching for a "Secret" to Beating Cancer — Telling Unproven Remedies and Supplements Apart from Evidence-Based Habits
There is no single magic cure that beats cancer at once; the everyday basics — not smoking, a balanced diet, activity, sleep, and screening — are what evidence actually supports. This piece explains how to spot exaggerated remedies and high-dose supplements, and why to check with your care team before trying anything new.
The pathology says 'no cancer left' — can you still get preventive immunotherapy? Understanding a pathologic complete response (ypT0N0) and how adjuvant treatment is decided
After neoadjuvant chemo and surgery, a pathology report may show no remaining cancer (pathologic complete response, ypT0N0). This explains what that means and how the choice about preventive or adjuvant immunotherapy is guided by evidence, side effects and individual risk — not by request alone.
When an Older Loved One Suddenly Sees Things and Can't Sleep After Surgery — Understanding Postoperative Delirium in Frail, Older Patients and Waiting for It to Pass
Older patients, and especially those with a prior stroke or cognitive decline, often develop delirium within days of major surgery. This piece explains what postoperative delirium is, why it usually eases once its causes are addressed, how families can help at the bedside, and which warning signs mean the care team should be told at once.
Surgery Went Well — So Why Recommend Chemo? Understanding Adjuvant Chemotherapy for Stage 3 Colorectal Cancer and Deciding Together When an Older Patient Hesitates
Why doctors recommend adjuvant chemotherapy after surgery for stage 3 colorectal cancer — to target unseen micrometastasis and lower recurrence risk — and how to weigh benefits and burdens together when an older patient hesitates.
When Blood Sugar Swings During Cancer Treatment — Why Sleep, Stress, and Hormones Move Your Glucose, and the Diabetes Screenings (Eyes, Kidneys, Feet) That Are Easy to Miss
Why blood sugar becomes erratic during cancer treatment — sleep, hormonal shifts, steroids, and stress — the role of rest, and the diabetes complication screenings (eyes, kidneys, feet) that are easy to miss.